Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer

American Journal of Epidemiology

Volumn 145, Issue 7, 1997, Pages 607-613

  Heath Jr , Clark W ^a   Lally, Cathy A ^a   Calle, Eugenia E ^a   McLaughlin, Joseph K ^b   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

antihypertensive agents; diuretics; hypertension; kidney; kidney neoplasms

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CANCER RISK; CIGARETTE SMOKING; DISEASE SEVERITY; DIURESIS; FEMALE; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE;

EID: 1842372047     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009157     Document Type: Article

References (32)

1. McLaughlin JK, Mandel JS, Blot WJ, et al. A population-based case-control study of renal cell carcinoma. J Natl Cancer Inst 1984;72:275-89.
2. McLaughlin JK, Blot WJ, Fraumeni JF Jr. Diuretics and renal cell cancer. (Letter). J Natl Cancer Inst 1988;80:378.
3. Yu MC, Mack TM, Hanisch R, et al. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 1986;77:351-6.
4. Asal NR, Geyer JR, Risser DR, et al. Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate anal- ysis, and conclusions. Cancer Detect Prev 1988;13:263-79.
5. Fraser GE, Phillips RL, Beeson WL. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists. Int J Epidemiol 1990;19:832-8.
6. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991;134:942-7.
7. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 1992;3:323-31.
8. Mellemgaard A, Moller H, Olsen JH. Diuretics may increase risk of renal cell carcinoma. Cancer Causes Control 1992;3: 309-12.
9. Kreiger N, Marrett LD, Dodds L, et al. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993;4:101-10.
10. Finkle WD, McLaughlin JK, Rasgon SA, et al. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 1993;4:555-8.
11. Lindblad P, McLaughlin JK, Mellemgaard A, et al. Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study. Int J Cancer 1993;55:5-9.
12. Hiatt RA, Tolan K, Quesenberry CP Jr. Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control 1994;5:319-25.
13. Mellemgaard A, Niwa S, Mehl ES, et al. Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 1994;23:923-30.
14. Weinmann S, Glass AG, Weiss NS, et al. Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol 1994;140:792-804.
15. Muscat JE, Hoffmann D, Wynder EL. The epidemiology of renal cell carcinoma: a second look. Cancer 1995;75:2552-7.
16. Chow WH, McLaughlin JK, Mandel JS, et al. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol Biomarkers Prev 1995;4: 327-31.
17. McLaughlin JK, Chow WH, Mandel JS, et al. International renal-cell cancer study. VIII. Role of diuretics, other antihypertensive medications and hypertension. Int J Cancer 1995:63:216-21.
18. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993;137:235-41.
19. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Vol 1. Geneva: World Health Organization, 1977.
20. National Center for Health Statistics, McDowell A, Engel A, et al. Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980. Washington, DC: US GPO, 1981. (Vital and Health Statistics, Series 1: programs and collection procedures, no. 15). (DHHS publication no. (PHS)81-1317).
21. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B) 1972;34:187-220.
22. McLaughlin JK, Lindblad P, Mellemgaard A, et al. International renal-cell cancer study. I. Tobacco use. Int J Cancer 1995;60:194-8.
23. Chow WH, McLaughlin JK, Mandel JS, et al Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 1996; 5:17-21.
24. Chow WH, McLaughlin JK, Linet MS, et al. Use of analgesics and risk of renal cell cancer. Int J Cancer 1994;59:467-70.
25. McCredie M, Stewart JH, Day NE. Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer 1993;53:245-9.
26. Derby LE, Jick H. Acetaminophen and renal and bladder cancer. Epidemiology 1996;7:358-62.
27. Maclure M, MacMahon B. Phenacetin and cancers of the urinary tract. (Letter). N Engl J Med 1985;313:1479-80.
28. McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer 1988;42:13-16.
29. McLaughlin JK, Gao Y-T, Gao R-N, et al. Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer 1992;52: 562-5.
30. Lijinsky W, Reuber MD. Pathologic effects of chronic administration of hydrochlorothiazide, with and without sodium nitrite, to F344 rats. Toxicol Ind Health 1987;3:413-22.
31. Pahor M, Guralnik JM, Salive ME, et al. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9:695-9.
32. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-7.